Samuel Mackintosh
Concepts (456)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Proteomics | 20 | 2023 | 330 | 1.950 |
Why?
| Proteome | 13 | 2024 | 173 | 1.530 |
Why?
| Histones | 9 | 2023 | 313 | 1.070 |
Why?
| Chromatin | 7 | 2024 | 152 | 0.850 |
Why?
| Saccharomyces cerevisiae Proteins | 7 | 2019 | 154 | 0.730 |
Why?
| DNA-Binding Proteins | 7 | 2021 | 428 | 0.690 |
Why?
| Viral Nonstructural Proteins | 4 | 2021 | 56 | 0.600 |
Why?
| Animals | 35 | 2024 | 13246 | 0.520 |
Why?
| Saccharomyces cerevisiae | 6 | 2019 | 189 | 0.520 |
Why?
| Protein Interaction Mapping | 4 | 2020 | 40 | 0.510 |
Why?
| Transcription Factors | 8 | 2021 | 564 | 0.500 |
Why?
| Mice | 23 | 2024 | 5759 | 0.480 |
Why?
| DNA Helicases | 3 | 2021 | 144 | 0.480 |
Why?
| Ubiquitin-Protein Ligases | 3 | 2024 | 95 | 0.450 |
Why?
| Bacterial Proteins | 4 | 2019 | 376 | 0.430 |
Why?
| DNA | 4 | 2015 | 541 | 0.430 |
Why?
| Interferon Type I | 2 | 2023 | 25 | 0.410 |
Why?
| Intracellular Signaling Peptides and Proteins | 2 | 2023 | 143 | 0.410 |
Why?
| Hepacivirus | 3 | 2010 | 104 | 0.400 |
Why?
| G-Quadruplexes | 3 | 2019 | 80 | 0.390 |
Why?
| Chromosomal Proteins, Non-Histone | 2 | 2021 | 40 | 0.370 |
Why?
| Melanoma | 3 | 2024 | 290 | 0.370 |
Why?
| Virus Replication | 2 | 2015 | 140 | 0.360 |
Why?
| Aging | 3 | 2024 | 688 | 0.360 |
Why?
| Tandem Mass Spectrometry | 7 | 2020 | 231 | 0.360 |
Why?
| Protein Binding | 10 | 2021 | 665 | 0.350 |
Why?
| Protein Processing, Post-Translational | 6 | 2020 | 171 | 0.350 |
Why?
| Mass Spectrometry | 8 | 2021 | 301 | 0.350 |
Why?
| Lysine | 2 | 2023 | 89 | 0.340 |
Why?
| Phosphoproteins | 2 | 2020 | 108 | 0.340 |
Why?
| Proteolysis | 4 | 2023 | 95 | 0.320 |
Why?
| Staphylococcus aureus | 3 | 2019 | 327 | 0.300 |
Why?
| Cell Cycle Checkpoints | 2 | 2019 | 32 | 0.300 |
Why?
| Signal Transduction | 7 | 2024 | 1622 | 0.300 |
Why?
| Humans | 40 | 2024 | 50208 | 0.290 |
Why?
| Bone Resorption | 2 | 2022 | 302 | 0.290 |
Why?
| Renal Insufficiency, Chronic | 2 | 2020 | 169 | 0.280 |
Why?
| Osteoclasts | 2 | 2022 | 428 | 0.270 |
Why?
| HEK293 Cells | 6 | 2021 | 224 | 0.260 |
Why?
| Caenorhabditis elegans | 2 | 2016 | 138 | 0.260 |
Why?
| DNA Replication | 1 | 2006 | 150 | 0.260 |
Why?
| Gene Silencing | 2 | 2023 | 118 | 0.250 |
Why?
| Co-Repressor Proteins | 2 | 2023 | 20 | 0.250 |
Why?
| Nuclear Proteins | 2 | 2016 | 243 | 0.240 |
Why?
| Glucuronidase | 1 | 2024 | 46 | 0.240 |
Why?
| Sirtuin 1 | 1 | 2024 | 28 | 0.240 |
Why?
| Diastole | 1 | 2024 | 71 | 0.240 |
Why?
| Chiroptera | 1 | 2023 | 5 | 0.230 |
Why?
| Retroelements | 1 | 2023 | 14 | 0.230 |
Why?
| Mediator Complex | 1 | 2023 | 5 | 0.230 |
Why?
| Endogenous Retroviruses | 1 | 2023 | 8 | 0.230 |
Why?
| Viruses | 1 | 2023 | 22 | 0.220 |
Why?
| Cyclin-Dependent Kinases | 1 | 2023 | 28 | 0.220 |
Why?
| Membrane Proteins | 2 | 2016 | 353 | 0.220 |
Why?
| Gene Expression Regulation, Neoplastic | 4 | 2021 | 828 | 0.220 |
Why?
| Uterine Cervical Neoplasms | 2 | 2016 | 276 | 0.220 |
Why?
| Mice, Knockout | 6 | 2024 | 846 | 0.220 |
Why?
| Cell Cycle Proteins | 2 | 2021 | 166 | 0.220 |
Why?
| Polycomb Repressive Complex 2 | 2 | 2021 | 47 | 0.210 |
Why?
| Methionine | 1 | 2024 | 135 | 0.210 |
Why?
| Trans-Activators | 2 | 2019 | 134 | 0.210 |
Why?
| NF-E2-Related Factor 2 | 1 | 2023 | 41 | 0.210 |
Why?
| Idiopathic Pulmonary Fibrosis | 1 | 2022 | 9 | 0.210 |
Why?
| Epigenesis, Genetic | 4 | 2023 | 378 | 0.210 |
Why?
| Cecum | 2 | 2021 | 63 | 0.210 |
Why?
| Peripheral Nerve Injuries | 1 | 2022 | 24 | 0.210 |
Why?
| Receptors, Transferrin | 1 | 2022 | 16 | 0.210 |
Why?
| Mice, Inbred C57BL | 7 | 2024 | 1819 | 0.210 |
Why?
| Ikaros Transcription Factor | 1 | 2022 | 6 | 0.210 |
Why?
| Intellectual Disability | 1 | 2024 | 124 | 0.210 |
Why?
| Osteogenesis Imperfecta | 2 | 2020 | 38 | 0.200 |
Why?
| Histone Acetyltransferases | 2 | 2014 | 22 | 0.200 |
Why?
| Cell Proliferation | 4 | 2021 | 1013 | 0.200 |
Why?
| Mutation | 7 | 2020 | 1294 | 0.200 |
Why?
| Liver Failure, Acute | 1 | 2022 | 54 | 0.200 |
Why?
| DEAD-box RNA Helicases | 2 | 2019 | 34 | 0.200 |
Why?
| Nuclear Pore Complex Proteins | 1 | 2021 | 9 | 0.200 |
Why?
| T-Lymphocytes | 2 | 2021 | 339 | 0.200 |
Why?
| End Stage Liver Disease | 1 | 2022 | 45 | 0.190 |
Why?
| Phosphofructokinase-1, Type C | 1 | 2021 | 4 | 0.190 |
Why?
| Early Growth Response Protein 1 | 1 | 2021 | 35 | 0.190 |
Why?
| YY1 Transcription Factor | 1 | 2021 | 7 | 0.190 |
Why?
| Polycomb-Group Proteins | 1 | 2021 | 9 | 0.190 |
Why?
| DNA-Activated Protein Kinase | 1 | 2021 | 26 | 0.190 |
Why?
| Iron | 1 | 2022 | 122 | 0.190 |
Why?
| Neoplasms | 2 | 2021 | 1249 | 0.190 |
Why?
| Cadherins | 2 | 2019 | 68 | 0.190 |
Why?
| Cell Line | 5 | 2023 | 1021 | 0.190 |
Why?
| Uterine Artery | 1 | 2021 | 3 | 0.190 |
Why?
| Lymphocyte Activation | 1 | 2021 | 172 | 0.190 |
Why?
| Ozone | 1 | 2021 | 19 | 0.190 |
Why?
| Carcinoma, Hepatocellular | 1 | 2023 | 193 | 0.190 |
Why?
| Homeodomain Proteins | 1 | 2021 | 80 | 0.190 |
Why?
| Septins | 1 | 2020 | 19 | 0.190 |
Why?
| Cryptococcus neoformans | 1 | 2020 | 27 | 0.180 |
Why?
| Apoptosis | 3 | 2021 | 1112 | 0.180 |
Why?
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2020 | 55 | 0.180 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 131 | 0.180 |
Why?
| Vanadates | 1 | 2020 | 8 | 0.180 |
Why?
| Phosphotyrosine | 1 | 2020 | 7 | 0.180 |
Why?
| Adenine | 2 | 2019 | 32 | 0.180 |
Why?
| Neoplasms, Experimental | 1 | 2020 | 114 | 0.170 |
Why?
| Infant Formula | 1 | 2021 | 143 | 0.170 |
Why?
| Lymphocytes, Tumor-Infiltrating | 1 | 2020 | 78 | 0.170 |
Why?
| Multiple Myeloma | 3 | 2021 | 2954 | 0.170 |
Why?
| Extracellular Matrix Proteins | 1 | 2020 | 69 | 0.170 |
Why?
| Molecular Chaperones | 1 | 2020 | 65 | 0.170 |
Why?
| Fungal Proteins | 1 | 2020 | 119 | 0.170 |
Why?
| DNA Damage | 2 | 2024 | 301 | 0.170 |
Why?
| Liver Neoplasms | 1 | 2023 | 328 | 0.170 |
Why?
| Alanine Transaminase | 1 | 2020 | 124 | 0.170 |
Why?
| Translocation, Genetic | 1 | 2021 | 264 | 0.170 |
Why?
| Poly(A)-Binding Proteins | 1 | 2019 | 6 | 0.170 |
Why?
| Carrier Proteins | 1 | 2021 | 306 | 0.170 |
Why?
| Ribonucleoproteins | 1 | 2019 | 17 | 0.170 |
Why?
| Collagen Type I | 1 | 2020 | 88 | 0.170 |
Why?
| Protein Kinases | 1 | 2019 | 71 | 0.170 |
Why?
| Xenopus Proteins | 1 | 2019 | 27 | 0.170 |
Why?
| Lymphoma, Mantle-Cell | 1 | 2019 | 18 | 0.170 |
Why?
| Ruminococcus | 1 | 2019 | 8 | 0.160 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2021 | 185 | 0.160 |
Why?
| Repressor Proteins | 2 | 2019 | 153 | 0.160 |
Why?
| Starch | 1 | 2019 | 13 | 0.160 |
Why?
| Integrin alpha Chains | 1 | 2019 | 11 | 0.160 |
Why?
| Oxidative Phosphorylation | 1 | 2019 | 40 | 0.160 |
Why?
| Virulence Factors | 1 | 2019 | 78 | 0.160 |
Why?
| Arsenic | 1 | 2019 | 24 | 0.160 |
Why?
| Methylation | 4 | 2023 | 123 | 0.160 |
Why?
| Drug Resistance, Neoplasm | 2 | 2019 | 314 | 0.160 |
Why?
| Melanoma, Experimental | 1 | 2019 | 45 | 0.160 |
Why?
| Adaptor Proteins, Signal Transducing | 3 | 2022 | 198 | 0.160 |
Why?
| Computational Biology | 1 | 2020 | 216 | 0.160 |
Why?
| Molecular Targeted Therapy | 1 | 2019 | 121 | 0.160 |
Why?
| Osteomyelitis | 1 | 2019 | 126 | 0.160 |
Why?
| Oligonucleotides | 3 | 2008 | 81 | 0.160 |
Why?
| Antineoplastic Agents | 3 | 2022 | 1186 | 0.150 |
Why?
| Cell Line, Tumor | 5 | 2021 | 1416 | 0.150 |
Why?
| Peptide Hydrolases | 1 | 2018 | 62 | 0.150 |
Why?
| Protein Biosynthesis | 2 | 2019 | 254 | 0.150 |
Why?
| Software | 1 | 2020 | 271 | 0.150 |
Why?
| Diet | 1 | 2021 | 557 | 0.150 |
Why?
| Antigens, CD | 1 | 2019 | 221 | 0.150 |
Why?
| Host-Pathogen Interactions | 2 | 2016 | 135 | 0.150 |
Why?
| Nerve Tissue Proteins | 1 | 2019 | 193 | 0.150 |
Why?
| Kinetics | 4 | 2019 | 631 | 0.150 |
Why?
| Up-Regulation | 2 | 2016 | 453 | 0.140 |
Why?
| CTLA-4 Antigen | 1 | 2017 | 25 | 0.140 |
Why?
| Breast Neoplasms | 2 | 2016 | 1179 | 0.140 |
Why?
| Histone Code | 1 | 2017 | 32 | 0.140 |
Why?
| Programmed Cell Death 1 Receptor | 1 | 2017 | 39 | 0.140 |
Why?
| Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 17 | 0.140 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 1 | 2016 | 37 | 0.140 |
Why?
| Blood Proteins | 1 | 2017 | 82 | 0.140 |
Why?
| RNA, Messenger | 2 | 2019 | 1108 | 0.140 |
Why?
| Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 10 | 0.140 |
Why?
| 3' Untranslated Regions | 1 | 2016 | 52 | 0.140 |
Why?
| Butadienes | 1 | 2017 | 48 | 0.140 |
Why?
| Mitochondria, Liver | 1 | 2017 | 70 | 0.140 |
Why?
| Neoplasm Proteins | 2 | 2016 | 324 | 0.140 |
Why?
| Phosphatidylinositol Phosphates | 1 | 2016 | 15 | 0.140 |
Why?
| Vesicular Transport Proteins | 1 | 2016 | 39 | 0.140 |
Why?
| Muscles | 1 | 2016 | 102 | 0.140 |
Why?
| rab GTP-Binding Proteins | 1 | 2016 | 37 | 0.140 |
Why?
| Mitosis | 1 | 2016 | 93 | 0.140 |
Why?
| Mice, Inbred BALB C | 3 | 2021 | 305 | 0.140 |
Why?
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 1 | 2016 | 7 | 0.140 |
Why?
| Cytoplasmic Granules | 1 | 2016 | 25 | 0.140 |
Why?
| Procollagen-Proline Dioxygenase | 1 | 2016 | 9 | 0.140 |
Why?
| Whole-Body Irradiation | 1 | 2017 | 131 | 0.140 |
Why?
| Cytochrome P-450 CYP2E1 | 1 | 2017 | 113 | 0.140 |
Why?
| Lysosomes | 1 | 2016 | 84 | 0.130 |
Why?
| Disease Models, Animal | 4 | 2024 | 1458 | 0.130 |
Why?
| Cytoplasm | 1 | 2016 | 91 | 0.130 |
Why?
| Kidney | 1 | 2020 | 672 | 0.130 |
Why?
| Protein Structure, Tertiary | 4 | 2014 | 253 | 0.130 |
Why?
| Autoantigens | 1 | 2016 | 60 | 0.130 |
Why?
| Viral Load | 1 | 2016 | 77 | 0.130 |
Why?
| Tumor Burden | 1 | 2016 | 131 | 0.130 |
Why?
| Human papillomavirus 16 | 1 | 2016 | 44 | 0.130 |
Why?
| Recombinant Proteins | 3 | 2019 | 487 | 0.130 |
Why?
| Chromatography, Liquid | 4 | 2020 | 225 | 0.130 |
Why?
| Rhadinovirus | 1 | 2015 | 17 | 0.130 |
Why?
| Antigens, Viral | 1 | 2015 | 44 | 0.130 |
Why?
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 140 | 0.130 |
Why?
| Carcinogens | 1 | 2017 | 198 | 0.130 |
Why?
| Cell Differentiation | 4 | 2021 | 650 | 0.130 |
Why?
| Mice, SCID | 3 | 2021 | 176 | 0.130 |
Why?
| Endoplasmic Reticulum | 1 | 2016 | 118 | 0.130 |
Why?
| Proteins | 1 | 2018 | 345 | 0.130 |
Why?
| Sequence Homology, Amino Acid | 1 | 2015 | 144 | 0.120 |
Why?
| Acetylation | 3 | 2021 | 97 | 0.120 |
Why?
| Transcriptional Activation | 3 | 2021 | 121 | 0.120 |
Why?
| Tetrahymena thermophila | 1 | 2014 | 3 | 0.120 |
Why?
| Heterochromatin | 1 | 2014 | 4 | 0.120 |
Why?
| Collagen | 1 | 2016 | 207 | 0.120 |
Why?
| Female | 13 | 2022 | 26635 | 0.120 |
Why?
| Protozoan Proteins | 1 | 2014 | 31 | 0.120 |
Why?
| Hippocampus | 1 | 2016 | 228 | 0.120 |
Why?
| Genetic Loci | 1 | 2014 | 49 | 0.120 |
Why?
| Histone-Lysine N-Methyltransferase | 1 | 2014 | 55 | 0.120 |
Why?
| Cells, Cultured | 4 | 2020 | 1581 | 0.120 |
Why?
| Papillomavirus Infections | 1 | 2016 | 155 | 0.110 |
Why?
| RNA | 2 | 2023 | 171 | 0.110 |
Why?
| Phosphorylation | 3 | 2023 | 534 | 0.110 |
Why?
| HeLa Cells | 3 | 2021 | 260 | 0.110 |
Why?
| Membrane Glycoproteins | 1 | 2014 | 246 | 0.110 |
Why?
| Antibodies, Monoclonal | 1 | 2017 | 460 | 0.110 |
Why?
| Lung Neoplasms | 1 | 2019 | 605 | 0.110 |
Why?
| Pancreatic Neoplasms | 1 | 2015 | 208 | 0.110 |
Why?
| Alzheimer Disease | 1 | 2016 | 317 | 0.100 |
Why?
| Gene Expression Profiling | 3 | 2023 | 1037 | 0.100 |
Why?
| Male | 9 | 2024 | 25399 | 0.100 |
Why?
| RNA Interference | 3 | 2016 | 179 | 0.100 |
Why?
| DNA Methylation | 1 | 2016 | 550 | 0.100 |
Why?
| Oxidative Stress | 1 | 2016 | 771 | 0.100 |
Why?
| Ligands | 3 | 2023 | 205 | 0.100 |
Why?
| Chromatography, High Pressure Liquid | 3 | 2019 | 327 | 0.100 |
Why?
| Animals, Newborn | 2 | 2023 | 368 | 0.100 |
Why?
| Nevus, Pigmented | 1 | 2011 | 35 | 0.100 |
Why?
| Oncogene Proteins, Fusion | 2 | 2021 | 58 | 0.090 |
Why?
| Jurkat Cells | 2 | 2021 | 29 | 0.090 |
Why?
| Enhancer Elements, Genetic | 3 | 2021 | 61 | 0.090 |
Why?
| Hypertension | 1 | 2016 | 537 | 0.090 |
Why?
| Cardiovascular Diseases | 1 | 2016 | 443 | 0.090 |
Why?
| Ovarian Neoplasms | 1 | 2014 | 447 | 0.090 |
Why?
| Ubiquitination | 2 | 2024 | 43 | 0.090 |
Why?
| Heat-Shock Response | 2 | 2020 | 28 | 0.090 |
Why?
| Gene Deletion | 3 | 2016 | 270 | 0.090 |
Why?
| Gene Expression Regulation, Bacterial | 3 | 2019 | 191 | 0.090 |
Why?
| Movement | 1 | 2010 | 84 | 0.090 |
Why?
| DNA, Viral | 1 | 2010 | 134 | 0.080 |
Why?
| Mitochondria | 2 | 2023 | 404 | 0.080 |
Why?
| Bacteria | 2 | 2021 | 222 | 0.080 |
Why?
| Rats | 3 | 2021 | 3299 | 0.080 |
Why?
| Albuminuria | 1 | 2009 | 47 | 0.080 |
Why?
| Mice, Inbred NOD | 2 | 2021 | 96 | 0.080 |
Why?
| RNA Helicases | 1 | 2008 | 29 | 0.080 |
Why?
| Virulence | 2 | 2019 | 173 | 0.080 |
Why?
| Receptors, Cell Surface | 1 | 2009 | 125 | 0.080 |
Why?
| Acetaminophen | 2 | 2022 | 283 | 0.080 |
Why?
| Dose-Response Relationship, Drug | 2 | 2016 | 1378 | 0.080 |
Why?
| Tumor Microenvironment | 2 | 2020 | 233 | 0.080 |
Why?
| DNA Copy Number Variations | 2 | 2019 | 110 | 0.070 |
Why?
| Biofilms | 2 | 2019 | 181 | 0.070 |
Why?
| Cockayne Syndrome | 1 | 2006 | 3 | 0.070 |
Why?
| Bloom Syndrome | 1 | 2006 | 4 | 0.070 |
Why?
| Disease Progression | 2 | 2020 | 831 | 0.070 |
Why?
| Werner Syndrome | 1 | 2006 | 15 | 0.070 |
Why?
| Eukaryotic Cells | 1 | 2006 | 19 | 0.070 |
Why?
| MCF-7 Cells | 2 | 2016 | 69 | 0.070 |
Why?
| Diabetes Mellitus, Type 1 | 1 | 2009 | 201 | 0.070 |
Why?
| Gene Knockdown Techniques | 2 | 2016 | 106 | 0.070 |
Why?
| RNA, Small Interfering | 2 | 2018 | 215 | 0.070 |
Why?
| Recombination, Genetic | 1 | 2006 | 96 | 0.070 |
Why?
| Mutation, Missense | 2 | 2021 | 105 | 0.070 |
Why?
| Spectrophotometry | 1 | 2005 | 32 | 0.070 |
Why?
| Rats, Sprague-Dawley | 2 | 2021 | 1586 | 0.070 |
Why?
| Skin Neoplasms | 1 | 2011 | 492 | 0.070 |
Why?
| Dimerization | 1 | 2005 | 50 | 0.070 |
Why?
| Cytokines | 2 | 2021 | 613 | 0.070 |
Why?
| Adenosine Triphosphatases | 1 | 2005 | 87 | 0.060 |
Why?
| Crystallography, X-Ray | 1 | 2005 | 148 | 0.060 |
Why?
| Plasmids | 1 | 2005 | 161 | 0.060 |
Why?
| Protein Conformation | 1 | 2005 | 168 | 0.060 |
Why?
| Genome, Viral | 1 | 2005 | 79 | 0.060 |
Why?
| Gene Expression Regulation, Fungal | 2 | 2019 | 52 | 0.060 |
Why?
| Cell Membrane | 1 | 2005 | 251 | 0.060 |
Why?
| Models, Molecular | 1 | 2005 | 341 | 0.060 |
Why?
| Models, Statistical | 1 | 2005 | 224 | 0.060 |
Why?
| Blotting, Western | 1 | 2005 | 601 | 0.060 |
Why?
| Jamaica | 1 | 2023 | 9 | 0.060 |
Why?
| Terminal Repeat Sequences | 1 | 2023 | 11 | 0.060 |
Why?
| S-Adenosylmethionine | 1 | 2024 | 63 | 0.060 |
Why?
| Hepatitis B virus | 1 | 2023 | 27 | 0.060 |
Why?
| Adhesins, Bacterial | 1 | 2003 | 27 | 0.060 |
Why?
| Organoids | 1 | 2023 | 40 | 0.060 |
Why?
| Microvessels | 1 | 2023 | 31 | 0.060 |
Why?
| Genome | 1 | 2023 | 65 | 0.060 |
Why?
| Homocysteine | 1 | 2024 | 128 | 0.050 |
Why?
| Histone Deacetylases | 1 | 2023 | 51 | 0.050 |
Why?
| Models, Biological | 1 | 2006 | 723 | 0.050 |
Why?
| Sural Nerve | 1 | 2022 | 8 | 0.050 |
Why?
| DNA, Bacterial | 1 | 2003 | 188 | 0.050 |
Why?
| Nerve Regeneration | 1 | 2022 | 21 | 0.050 |
Why?
| Young Adult | 3 | 2016 | 3981 | 0.050 |
Why?
| Reference Values | 2 | 2016 | 310 | 0.050 |
Why?
| Peripheral Nerves | 1 | 2022 | 49 | 0.050 |
Why?
| Cytoskeleton | 1 | 2022 | 41 | 0.050 |
Why?
| L-Lactate Dehydrogenase | 1 | 2022 | 66 | 0.050 |
Why?
| Hepatocytes | 1 | 2023 | 182 | 0.050 |
Why?
| Antiviral Agents | 1 | 2023 | 173 | 0.050 |
Why?
| Substrate Specificity | 2 | 2015 | 193 | 0.050 |
Why?
| Genomics | 1 | 2024 | 285 | 0.050 |
Why?
| Protein Stability | 1 | 2021 | 44 | 0.050 |
Why?
| Influenza A virus | 1 | 2021 | 17 | 0.050 |
Why?
| Vero Cells | 1 | 2021 | 45 | 0.050 |
Why?
| Echocardiography | 1 | 2024 | 375 | 0.050 |
Why?
| Chromatin Assembly and Disassembly | 1 | 2021 | 25 | 0.050 |
Why?
| Mutagenesis, Site-Directed | 1 | 2021 | 99 | 0.050 |
Why?
| Gene Expression Regulation, Leukemic | 1 | 2021 | 33 | 0.050 |
Why?
| Cryptococcosis | 1 | 2020 | 20 | 0.050 |
Why?
| Glycolysis | 1 | 2021 | 70 | 0.050 |
Why?
| Models, Animal | 1 | 2021 | 232 | 0.050 |
Why?
| Promoter Regions, Genetic | 2 | 2019 | 475 | 0.050 |
Why?
| Blood Urea Nitrogen | 1 | 2020 | 41 | 0.050 |
Why?
| Genome, Human | 1 | 2021 | 111 | 0.050 |
Why?
| Milk, Human | 1 | 2021 | 104 | 0.050 |
Why?
| Formaldehyde | 2 | 2011 | 52 | 0.050 |
Why?
| Phosphopeptides | 1 | 2020 | 5 | 0.040 |
Why?
| Swine | 1 | 2021 | 396 | 0.040 |
Why?
| Amino Acid Motifs | 1 | 2020 | 57 | 0.040 |
Why?
| Workflow | 1 | 2020 | 51 | 0.040 |
Why?
| Adenosylhomocysteinase | 1 | 2020 | 10 | 0.040 |
Why?
| Ions | 1 | 2020 | 33 | 0.040 |
Why?
| Time Factors | 2 | 2017 | 2922 | 0.040 |
Why?
| Transcription, Genetic | 1 | 2021 | 369 | 0.040 |
Why?
| Alcohol Dehydrogenase | 1 | 2020 | 38 | 0.040 |
Why?
| Aldehyde Dehydrogenase | 1 | 2020 | 26 | 0.040 |
Why?
| Drug Discovery | 1 | 2020 | 88 | 0.040 |
Why?
| Cell Transformation, Neoplastic | 1 | 2021 | 179 | 0.040 |
Why?
| Neoplastic Stem Cells | 1 | 2021 | 103 | 0.040 |
Why?
| Databases, Genetic | 1 | 2020 | 88 | 0.040 |
Why?
| Poly(A)-Binding Protein I | 1 | 2019 | 6 | 0.040 |
Why?
| Oogenesis | 1 | 2019 | 16 | 0.040 |
Why?
| Rats, Wistar | 1 | 2020 | 222 | 0.040 |
Why?
| Polyadenylation | 1 | 2019 | 20 | 0.040 |
Why?
| Placenta | 1 | 2021 | 132 | 0.040 |
Why?
| Xenopus laevis | 1 | 2019 | 38 | 0.040 |
Why?
| Arsenate Reductases | 1 | 2019 | 5 | 0.040 |
Why?
| Basic-Leucine Zipper Transcription Factors | 1 | 2019 | 12 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2021 | 184 | 0.040 |
Why?
| Base Sequence | 2 | 2015 | 644 | 0.040 |
Why?
| Membrane Transport Proteins | 1 | 2019 | 49 | 0.040 |
Why?
| Binding Sites | 2 | 2014 | 375 | 0.040 |
Why?
| Oocytes | 1 | 2019 | 74 | 0.040 |
Why?
| Severity of Illness Index | 1 | 2022 | 951 | 0.040 |
Why?
| Heart Failure | 1 | 2024 | 506 | 0.040 |
Why?
| Lung | 1 | 2022 | 490 | 0.040 |
Why?
| Piperidines | 1 | 2019 | 98 | 0.040 |
Why?
| RNA-Binding Proteins | 1 | 2019 | 123 | 0.040 |
Why?
| Pyrazoles | 1 | 2019 | 114 | 0.040 |
Why?
| Cell Cycle | 1 | 2019 | 232 | 0.040 |
Why?
| Tumor Cells, Cultured | 1 | 2019 | 468 | 0.040 |
Why?
| CD8-Positive T-Lymphocytes | 1 | 2019 | 128 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2019 | 233 | 0.040 |
Why?
| Drug Overdose | 1 | 2020 | 163 | 0.040 |
Why?
| Pyrimidines | 1 | 2019 | 193 | 0.040 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 76 | 0.040 |
Why?
| Mitochondrial Proteins | 1 | 2018 | 90 | 0.040 |
Why?
| Dexamethasone | 1 | 2020 | 430 | 0.040 |
Why?
| Electron Transport Complex III | 1 | 2017 | 7 | 0.040 |
Why?
| Electrophoresis, Polyacrylamide Gel | 1 | 2017 | 103 | 0.040 |
Why?
| Succinate Dehydrogenase | 1 | 2017 | 23 | 0.040 |
Why?
| Macaca mulatta | 1 | 2017 | 93 | 0.040 |
Why?
| Retinoblastoma-Binding Protein 2 | 1 | 2016 | 6 | 0.040 |
Why?
| CDC2 Protein Kinase | 1 | 2016 | 16 | 0.040 |
Why?
| Ribonuclease III | 1 | 2016 | 12 | 0.040 |
Why?
| Electron Transport Complex IV | 1 | 2017 | 29 | 0.040 |
Why?
| Electron Transport Complex I | 1 | 2017 | 23 | 0.040 |
Why?
| Epithelial-Mesenchymal Transition | 1 | 2017 | 48 | 0.040 |
Why?
| Vinblastine | 1 | 2016 | 23 | 0.040 |
Why?
| Gamma Rays | 1 | 2017 | 49 | 0.040 |
Why?
| Prognosis | 1 | 2022 | 1954 | 0.040 |
Why?
| Tubulin Modulators | 1 | 2016 | 31 | 0.040 |
Why?
| Cyclin D1 | 1 | 2016 | 56 | 0.030 |
Why?
| Staphylococcal Infections | 1 | 2019 | 269 | 0.030 |
Why?
| Transcriptome | 1 | 2019 | 320 | 0.030 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2017 | 184 | 0.030 |
Why?
| Intermediate Filament Proteins | 1 | 2016 | 12 | 0.030 |
Why?
| Endosomes | 1 | 2016 | 33 | 0.030 |
Why?
| Detergents | 1 | 2016 | 17 | 0.030 |
Why?
| Cluster Analysis | 1 | 2017 | 235 | 0.030 |
Why?
| Thermodynamics | 1 | 2016 | 33 | 0.030 |
Why?
| tau Proteins | 1 | 2016 | 26 | 0.030 |
Why?
| 14-3-3 Proteins | 1 | 2016 | 18 | 0.030 |
Why?
| Codon, Nonsense | 1 | 2016 | 26 | 0.030 |
Why?
| Thiolester Hydrolases | 1 | 2016 | 7 | 0.030 |
Why?
| Cyclophilins | 1 | 2016 | 9 | 0.030 |
Why?
| Catalytic Domain | 1 | 2016 | 57 | 0.030 |
Why?
| X Chromosome | 1 | 2016 | 13 | 0.030 |
Why?
| Ubiquitin Thiolesterase | 1 | 2016 | 18 | 0.030 |
Why?
| Vaccines, Subunit | 1 | 2016 | 15 | 0.030 |
Why?
| Hydroxylation | 1 | 2016 | 61 | 0.030 |
Why?
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2016 | 16 | 0.030 |
Why?
| Solubility | 1 | 2016 | 71 | 0.030 |
Why?
| Cell Survival | 1 | 2018 | 602 | 0.030 |
Why?
| Adult | 3 | 2016 | 13324 | 0.030 |
Why?
| Reactive Oxygen Species | 1 | 2018 | 408 | 0.030 |
Why?
| Mammals | 1 | 2016 | 58 | 0.030 |
Why?
| Long Interspersed Nucleotide Elements | 1 | 2016 | 38 | 0.030 |
Why?
| Centrifugation | 1 | 2015 | 14 | 0.030 |
Why?
| Endopeptidases | 1 | 2016 | 66 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2015 | 44 | 0.030 |
Why?
| DNA Transposable Elements | 1 | 2016 | 107 | 0.030 |
Why?
| Tissue Distribution | 1 | 2016 | 163 | 0.030 |
Why?
| Hydrogen Peroxide | 1 | 2016 | 115 | 0.030 |
Why?
| Protein Interaction Maps | 1 | 2015 | 23 | 0.030 |
Why?
| Immunoprecipitation | 1 | 2015 | 59 | 0.030 |
Why?
| DNA, Mitochondrial | 1 | 2017 | 113 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2016 | 86 | 0.030 |
Why?
| Lipids | 1 | 2016 | 148 | 0.030 |
Why?
| Myofibroblasts | 1 | 2016 | 49 | 0.030 |
Why?
| Cell Death | 1 | 2016 | 182 | 0.030 |
Why?
| Leukocytes, Mononuclear | 1 | 2016 | 115 | 0.030 |
Why?
| Extracellular Matrix | 1 | 2016 | 111 | 0.030 |
Why?
| Isotope Labeling | 1 | 2015 | 53 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2016 | 99 | 0.030 |
Why?
| Computer Simulation | 1 | 2016 | 280 | 0.030 |
Why?
| Homeostasis | 1 | 2016 | 201 | 0.030 |
Why?
| Transfection | 1 | 2016 | 355 | 0.030 |
Why?
| Brain | 1 | 2023 | 1328 | 0.030 |
Why?
| Neurodegenerative Diseases | 1 | 2016 | 78 | 0.030 |
Why?
| Neoplasm Metastasis | 1 | 2015 | 236 | 0.030 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2016 | 180 | 0.030 |
Why?
| N-Acetylglucosaminyltransferases | 1 | 2014 | 16 | 0.030 |
Why?
| Glycomics | 1 | 2014 | 9 | 0.030 |
Why?
| Micronucleus, Germline | 1 | 2014 | 2 | 0.030 |
Why?
| DNA, Protozoan | 1 | 2014 | 12 | 0.030 |
Why?
| Genotype | 1 | 2016 | 534 | 0.030 |
Why?
| Glycosylation | 1 | 2014 | 101 | 0.030 |
Why?
| Sequence Alignment | 1 | 2014 | 122 | 0.030 |
Why?
| Meiosis | 1 | 2014 | 56 | 0.030 |
Why?
| DNA Breaks, Double-Stranded | 1 | 2014 | 72 | 0.030 |
Why?
| Liver | 1 | 2020 | 1116 | 0.030 |
Why?
| Vaccination | 1 | 2016 | 271 | 0.030 |
Why?
| Pregnancy | 1 | 2021 | 2604 | 0.030 |
Why?
| Phenotype | 1 | 2016 | 733 | 0.030 |
Why?
| Amino Acid Sequence | 1 | 2014 | 586 | 0.030 |
Why?
| Case-Control Studies | 1 | 2016 | 1126 | 0.030 |
Why?
| Molecular Sequence Data | 1 | 2014 | 793 | 0.030 |
Why?
| Age Factors | 1 | 2016 | 1092 | 0.030 |
Why?
| Bone and Bones | 1 | 2016 | 475 | 0.030 |
Why?
| gp100 Melanoma Antigen | 1 | 2011 | 9 | 0.020 |
Why?
| Fixatives | 1 | 2011 | 13 | 0.020 |
Why?
| Tissue Fixation | 1 | 2011 | 37 | 0.020 |
Why?
| High-Throughput Screening Assays | 1 | 2011 | 36 | 0.020 |
Why?
| Paraffin Embedding | 1 | 2011 | 53 | 0.020 |
Why?
| Middle Aged | 2 | 2016 | 12206 | 0.020 |
Why?
| Fluorescein | 1 | 2010 | 8 | 0.020 |
Why?
| Streptavidin | 1 | 2010 | 16 | 0.020 |
Why?
| Least-Squares Analysis | 1 | 2010 | 43 | 0.020 |
Why?
| Spectrometry, Fluorescence | 1 | 2010 | 46 | 0.020 |
Why?
| Staining and Labeling | 1 | 2010 | 97 | 0.020 |
Why?
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2009 | 9 | 0.020 |
Why?
| DNA, Single-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
| Aged, 80 and over | 1 | 2016 | 3154 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2008 | 26 | 0.020 |
Why?
| Glomerular Filtration Rate | 1 | 2009 | 111 | 0.020 |
Why?
| RNA, Double-Stranded | 1 | 2008 | 21 | 0.020 |
Why?
| Amino Acid Substitution | 1 | 2008 | 82 | 0.020 |
Why?
| Diabetic Nephropathies | 1 | 2009 | 61 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2011 | 978 | 0.020 |
Why?
| Blood Pressure | 1 | 2009 | 524 | 0.020 |
Why?
| Consensus Sequence | 1 | 2003 | 24 | 0.010 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2003 | 73 | 0.010 |
Why?
| Aged | 1 | 2016 | 9405 | 0.010 |
Why?
|
|
Mackintosh's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|